Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 40kWORD 10k
3 March 2020
Question for written answer
to the Commission
Rule 138
Anja Hazekamp, Piernicola Pedicini
 Subject: German laboratory accused of fraud contributed to the EU’s assessment of glyphosate

The reliability of commercial research on glyphosate continues to be called into question. The Laboratory of Pharmacology and Toxicology (LPT), which was recently revealed to have committed acts of cruelty to animals and has delivered admission studies on glyphosate to the EU, is now suspected of having deliberately falsified research studies and is under investigation by the German Federal Public Prosecutor (1) .

1. Does the Commission agree that the authorisation of glyphosate now seems to be based on fraudulent studies that gravely underestimate the risks it poses and that it should therefore immediately be banned? If not, why not?

2. In the light of the above, does the Commission agree that current EU regulations and commercial practices based on the OECD Principles of Good Laboratory Practice – including supervision – do not effectively ensure the reliability of pesticide risk assessments, and if so, what will it do to remedy this?

3. Which safeguards, in addition to the amended General Food Law provisions, will the Commission implement in the light of this scandal and when will it guarantee that no studies from the LPT will ever again be used in EU risk management decisions, in order to guarantee that research on the safety of glyphosate is reliable?

Last updated: 19 March 2020Legal notice - Privacy policy